Trifarotene
DrugBank ID: DB12808
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 1 |
| DL Only | 49 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| acne (disease) | 0.9992 | KG+DL |
| zinc, elevated plasma | 0.9940 | DL |
| pyogenic arthritis-pyoderma gangrenosum-acne syndrome | 0.9932 | DL |
| demodicidosis of sebaceous gland | 0.9842 | DL |
| spondyloarthropathy, susceptibility to | 0.9826 | DL |
| malaria | 0.9757 | DL |
| Zollinger-Ellison syndrome | 0.9596 | DL |
| Ehlers-Danlos syndrome | 0.9553 | DL |
| Beare-Stevenson cutis gyrata syndrome | 0.9426 | DL |
| isolated congenital adermatoglyphia | 0.9414 | DL |
| malignant atrophic papulosis | 0.9388 | DL |
| drug-induced osteoporosis | 0.9296 | DL |
| autosomal dominant familial periodic fever | 0.9147 | DL |
| sterile multifocal osteomyelitis with periostitis and pustulosis | 0.9130 | DL |
| familial Mediterranean fever, autosomal dominant | 0.9123 | DL |
| ankylosing spondylitis | 0.9062 | DL |
| periodic fever-infantile enterocolitis-autoinflammatory syndrome | 0.9047 | DL |
| rheumatoid vasculitis | 0.9035 | DL |
| mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency | 0.8981 | DL |
| hyaline fibromatosis syndrome | 0.8935 | DL |
| inflammatory spondylopathy | 0.8922 | DL |
| hyperkeratosis-hyperpigmentation syndrome | 0.8921 | DL |
| Steel syndrome | 0.8909 | DL |
| Legius syndrome | 0.8881 | DL |
| Kimura disease | 0.8772 | DL |
| Kummell disease | 0.8765 | DL |
| dyshidrosis | 0.8756 | DL |
| hypermobility of coccyx | 0.8752 | DL |
| ataxia - telangiectasia variant | 0.8686 | DL |
| pseudo-von Willebrand disease | 0.8646 | DL |
| polyarticular juvenile rheumatoid arthritis | 0.8643 | DL |
| Blau syndrome | 0.8619 | DL |
| X-linked lymphoproliferative disease due to SH2D1A deficiency | 0.8579 | DL |
| primary release disorder of platelets | 0.8555 | DL |
| rheumatoid factor-negative juvenile idiopathic arthritis | 0.8512 | DL |
| systemic mastocytosis | 0.8469 | DL |
| lymphoadenopathic mastocytosis with eosinophilia | 0.8431 | DL |
| Smouldering systemic mastocytosis | 0.8410 | DL |
| discitis | 0.8397 | DL |
| A20 haploinsufficiency | 0.8355 | DL |
| immune dysregulation with inflammatory bowel disease | 0.8325 | DL |
| female genital tuberculosis | 0.8325 | DL |
| physiological sexual disorder | 0.8325 | DL |
| enthesitis-related juvenile idiopathic arthritis | 0.8321 | DL |
| pelvic organ prolapse | 0.8279 | DL |
| heparin cofactor 2 deficiency | 0.8250 | DL |
| microcephaly-congenital cataract-psoriasiform dermatitis syndrome | 0.8220 | DL |
| multicentric carpo-tarsal osteolysis with or without nephropathy | 0.8206 | DL |
| dyschondrosteosis-nephritis syndrome | 0.8194 | DL |
| leishmaniasis | 0.8192 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.